The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of CD38 knockout in NK cells on daratumumab-mediated cytotoxicity and cellular metabolism.
 
Yuya Nagai
No Relationships to Disclose
 
Meisam Naeimi Kararoudi
No Relationships to Disclose
 
Syed Abbas Ali
No Relationships to Disclose
 
Philip H. Imus
No Relationships to Disclose
 
Marcelo Pereira
No Relationships to Disclose
 
Ezgi Elmas
No Relationships to Disclose
 
Ivan Borrello
Leadership - WindMIL
Stock and Other Ownership Interests - WindMIL
Honoraria - Bristol-Myers Squibb; Celgene
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene
Speakers' Bureau - Bristol-Myers Squibb; Celgene
Research Funding - Bristol-Myers Squibb; Celgene
Patents, Royalties, Other Intellectual Property - WindMIL
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene
 
Dean Anthony Lee
Leadership - Cyto-Sen Therapeutics
Stock and Other Ownership Interests - Caribou Biosciences; Courier Therapeutics; Cyto-Sen Therapeutics
Honoraria - Miltenyi Biotec
Consulting or Advisory Role - Caribou Biosciences; Courier Therapeutics; Cyto-Sen Therapeutics; Intellia Therapeutics; Merck Sharp & Dohme
Patents, Royalties, Other Intellectual Property - US 60/925,830, PCT/US2008/061342 US 62/404,520 US 62/623,682 US 18/20,187
Travel, Accommodations, Expenses - Cyto-Sen Therapeutics; Merck Sharp & Dohme; Shire
 
Gabriel Ghiaur
No Relationships to Disclose